AI assistant
CALIX LIMITED — Director's Dealing 2022
Oct 24, 2022
64736_rns_2022-10-24_41c46e8a-6d46-4c21-bafa-7b701ddcda92.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [596 x 68] intentionally omitted <==
25 October 2022
Updates to 3Y notices for Phil Hodgson and Mark Sceats
Sydney, Australia | 25 October 2022 – Australian environmental technology company, Calix Limited (ASX: CXL) (“Calix” or the “Company”) confirms today the completion of an off-market selldown of a minor proportion of two Director’s shareholdings. The selldown was previously announced on 19 October 2022, as part of an institutional Placement (“Placement”) to raise $60m to accelerate commercialisation of Calix’s industrial decarbonisation technology.
To fund respective tax and debt obligations created by options vesting, Managing Director and Chief Executive Officer, Dr. Phil Hodgson and Executive Director and Chief Scientist, Dr. Mark Sceats have sold approximately 4% of each of their shareholdings (A$2.4m in aggregate at the placement price of A$4.55 per share) in conjunction with the Placement.
Both Dr. Hodgson and Dr. Sceats remain fully committed to Calix. Updated 3Y change in director interest forms for Dr. Hodgson and Dr. Sceats follow this notice.
This announcement has been authorised for release to the ASX by:
Phil Hodgson Managing Director and CEO Calix Limited 9-11 Bridge Street Pymble NSW 2073 Ph +61 2 8199 7400
==> picture [596 x 68] intentionally omitted <==
About Calix
Calix is a team of dedicated people who are urgently developing great businesses, leveraging our patented technology, that deliver positive global impact.
The core technology is being used to develop more environmentally-friendly solutions for water treatment, CO2 mitigation, biotechnology, advanced batteries, and more sustainable mineral and chemical processing.
Calix develops its technology via a global network of research and development collaborations, including governments, research institutes and universities, some of world’s largest companies, and a growing customer base and distributor network for its commercialised products and processes.
Because there’s only one Earth – Mars is for Quitters.
Website: https://www.calix.global/ Twitter: @CalixLimited YouTube: CalixLimited
For more information: Phil Hodgson Darren Charles Managing Director and CEO CFO and Company Secretary [email protected] [email protected] +61 2 8199 7400 +61 2 8199 7400
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity – Calix Limited ABN – 36 117 372 540
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Dr. Philip Hargraves Hodgson |
|---|---|
| Date of last notice | 13 October 2021 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
- |
| Date of change | 24/10/2022 |
| No. of securities held prior to change Pigeons Super Pty Limited Family A/C> (Director & beneficiary) Pigeon Investments Pty Ltd Discretionary A/C> (Trustee & beneficiary) Phil Hodgson Dr Philip Hargraves Hodgson |
2,188,280 Ordinary shares 800,024 Ordinary shares 1,106,925 Ordinary shares 1,239,383 Performance rights |
| Class | Fully Priced Ordinary Shares |
| Number acquired | - |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Number disposed | 193,407 |
|---|---|
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
$4.55 per ordinary share pursuant to an off-market trade managed as part of the Placement announced on 19 October 2022. |
| No. of securities held after change Pigeons Super Pty Limited Family A/C> (Director & beneficiary) Pigeon Investments Pty Ltd Discretionary A/C> (Trustee & beneficiary) Phil Hodgson Dr Philip Hargraves Hodgson |
2,193,059 Ordinary shares 606,617 Ordinary shares 1,311,148 Ordinary shares 1,035,160 Performance rights |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
193,407 sold pursuant to an off-market trade as announcement on 19 October 2022 to fund tax and loan obligations. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | - |
|---|---|
| Nature of interest | - |
| Name of registered holder (if issued securities) |
- |
| Date of change | - |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
- |
| Interest acquired | - |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Interest disposed | - |
|---|---|
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
- |
| Interest after change | - |
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
- |
| If prior written clearance was provided, on what date was this provided? |
- |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity – Calix Limited ABN – 36 117 372 540
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Dr. Mark Geoffrey Sceats |
|---|---|
| Date of last notice | 10 November 2021 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
- |
| Date of change | 24/10/2022 |
| No. of securities held prior to change Direct Mark Geoffrey Sceats Indirect Mark Geoffrey Sceats Fund> (Trustee & beneficiary) Elizabeth Elenius (Spouse) |
4,402,417 Ordinary shares 641,186 Unvested Performance rights 3,172,236 Ordinary shares 354,966 Ordinary shares |
| Class | Fully Paid Ordinary Shares |
| Number acquired | - |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Number disposed | 329,671 |
|---|---|
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
$4.55 per ordinary share pursuant to an off-market trade managed as part of the Placement announced on 19 October 2022. |
| No. of securities held after change Mark Geoffrey Sceats Mark Geoffrey Sceats Fund> (Trustee & beneficiary) Elizabeth Elenius (Spouse) |
4,402,417 Ordinary shares 641,186 Unvested Performance rights 2,847,344 Ordinary shares 404,466 Ordinary shares |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
329,671 sold pursuant to an off-market trade as announcement on 19 October 2022 to fund tax and loan obligations. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | - |
|---|---|
| Nature of interest | - |
| Name of registered holder (if issued securities) |
- |
| Date of change | - |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
- |
| Interest acquired | - |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
- Interest disposed Value/Consideration - Note: If consideration is non-cash, provide details and an estimated valuation - Interest after change
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
- |
| If prior written clearance was provided, on what date was this provided? |
- |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3